Evithe placeholder
520851A5-2236-40B4-798A-08D94622F841

Excellence through determination & commitment.

Our dedicated team and specialised support network allow for remarkable efficiency and groundbreaking results.

The team

Cynthia Hunefeld

Founder & CEO

Alan Sutton

Chief Science Officer

Alan provided contract bioanalysis on clinical trial samples for several major pharmaceutical companies. He joined GW Pharmaceuticals in 2001, forming and managing the analytical chemistry department developing methodologies for characterisation of complex botanical materials. 

Kylie Watt

CFO

Kylie Watt is a qualified Chartered Accountant with a Bachelor of Commerce degree in accounting, finance and information systems. Over the last 15 years she has gained experience in various accounting and finance roles across the areas of audit, business advisory, financial analysis, and commercial management. Kylie brings with her a combination of strong technical accounting knowledge and proficiency in financial management and analysis.

Dr Sebastian Ceron

Operations Assistant

Sebastian completed his training as a medical doctor, gaining clinical and research experience in international institutions. In 2024 he completed his Masters degree in Clinical Immunology at Victoria University to understand and apply the concepts of the immune system into clinical research.

John Clough

Director

Val Hooper

Director

Allan MacDonald

Director

Allan is an experienced director active in international markets for over 30 years. After successful careers with Mobil and Sony, he helped to establish the CSI (food) group of companies within New Zealand.

He has developed an extensive skill set through his involvement in opening and building international markets and scaling companies. With his skill in developing enduring relationships with clients, suppliers and other stakeholders – including overseeing complex contract negotiations and helping to guide innovative and groundbreaking Product development programs, he brings a wealth of experience to the Board to help with Evithé’s rapid growth.

Lorraine Thomson

Independent Director

A Master of Business Administration from New Zealand’s leading business school at the University of Auckland, Lorraine has a particular focus on innovation and strategic growth. She is an ArcAngel investor and an experienced company director on five boards, including the Gillies McIndoe Research Institute.

She is a former award-winning journalist, editor, publisher and author. Titles she has edited include New Zealand Pharmacy journal and also sub-editor of The National Business Review.

Dr Jane Calvert

Legal Advisor

Registered Trans-Tasman patent attorney with a PhD in Organic Chemistry. Jane has unique knowledge of both biotechnology and botanical drug development as well as the requirements for innovation and commercialisation pathways.

She brings a wealth of practical experience in building a companies intellectual property portfolio from start-up to large corporate from laboratory to public listing.

A lifelong commitment to bringing nature back into medicine.

The foundations for Evithé Biotechnology were already put in place by it’s Founder Cynthia when her father experienced a bacterial infection and Sepsis related organ failure  during her childhood. Her unrelenting curiosity and determination to create better treatment outcomes for others has been the driving force behind Evithé for over 20 years.

Watch an in-depth interview with Cynthia's journey in founding Evithé and her mission of commercially developing complex botanicals.

Contact us

At our current stage we welcome interest from investors, as well as those that have a desire to follow our developments.

Connect with Evithé through our digital channels in order to stay up to date.

Cynthia Hunefeld

Founder & CEO

Mrs Hunefeld dedicated her life, work and studies in ethnobotany, plant medicine, Post graduate Diploma in clinical research and Masters in Innovation & Commercialisation to the development of botanical medicines.

Alan Sutton

Chief Science Officer

Alan provided contract bioanalysis on clinical trial samples for several major pharmaceutical companies. He joined GW Pharmaceuticals in 2001, forming and managing the analytical chemistry department developing methodologies for characterisation of complex botanical materials.